By a combination of genome editing experiments and functional validation of the lipidomic results, we demonstrated that the altered lipid metabolism in neuroblastoma cells was likely mediated by the risk SNP rs2863002 via modulation of HSD17B12 expression. This evidence concerns the gene HSD17B12 and neuroblastoma.